Stroke Research and Treatment / 2018 / Article / Tab 6

Clinical Study

Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study

Table 6

ANOVARM models on cognitive domains.

TreatmentVisitTreatmentVisit
p-valuep-valuep-value

Psychomotor speedNon imputed0.17760.36400.0976
LOCF0.25230.68860.6286
Memory performanceNon imputed0.37440.06030.8072
LOCF0.65120.00110.3446
Global cognitive indexNon imputed0.84490.15480.9128
LOCF0.9332<0.00010.8932

General cognitive evaluationNon imputed0.69690.39130.5367
LOCF0.98610.02010.3556
Episodic memoryNon imputed0.90320.34660.6365
LOCF0.49480.09670.3351
Short-term memoryNon imputed0.27310.92640.9663
LOCF0.45430.96300.5808
Executive functionsNon imputed0.81230.62110.5504
LOCF0.09520.86170.4169
LanguageNon imputed0.27120.98910.9413
LOCF0.64220.70700.8942
Problem solvingNon imputed0.73870.70720.3618
LOCF0.84050.02240.0677
Dementia stagingNon imputed0.52260.16990.5337
LOCF0.64450.78730.4778
Daily living activitiesNon imputed0.40630.92330.9826
LOCF0.12880.99790.3036
Major psychiatric disordersNon imputed0.11390.38790.1515
LOCF0.10280.00790.4263

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.